Turki Al Hagbani Selected Research

Turki Al Hagbani Research Topics

2	COVID-19 11/2021 - 10/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2018 - 11/2018
1	Breast Neoplasms (Breast Cancer) 08/2023
1	Eye Infections 07/2023
1	Eye Diseases (Eye Disease) 07/2023
1	Lung Neoplasms (Lung Cancer) 02/2023
1	Carcinoma (Carcinomatosis) 02/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023
1	Neoplasms (Cancer) 02/2023
1	Hyperglycemia 05/2022
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Tuberculosis (Tuberculoses) 04/2022
1	Pulmonary Tuberculosis 04/2022
1	Confusion (Bewilderment) 03/2022
1	Fungal Lung Diseases 12/2021
1	Pulmonary Aspergillosis 12/2021
1	Bacterial Infections (Bacterial Infection) 11/2021
1	Infections 10/2021
1	Weight Gain 08/2021
1	Bites and Stings (Sting) 01/2018

3	CurcuminIBA 12/2018 - 01/2018
3	Chewing Gum (Chewing Gums)IBA 12/2018 - 01/2018
2	PowdersIBA 04/2022 - 01/2018
1	ChitosanIBA 08/2023
1	Tyrosine Kinase InhibitorsIBA 08/2023
1	biotin receptorIBA 08/2023
1	Carbon Nanotubes (Carbon Nanotube)IBA 08/2023
1	neratinibIBA 08/2023
1	besifloxacin FDA Link 07/2023
1	Methotrexate (Mexate)FDA LinkGeneric 02/2023
1	STA 9090IBA 02/2023
1	Therapeutic UsesIBA 02/2023
1	Glucose (Dextrose)FDA LinkGeneric 05/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 04/2022
1	Levofloxacin (Levaquin)FDA Link 04/2022
1	FluoroquinolonesIBA 04/2022
1	Dosage Forms (Dosage Form)IBA 03/2022
1	Excipients (Suspending Agents)IBA 12/2021
1	Antifungal AgentsIBA 12/2021
1	Terbinafine (Lamisil)FDA LinkGeneric 12/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	Third Generation CephalosporinsIBA 11/2021
1	VaccinesIBA 10/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 08/2021
1	PlasticsIBA 01/2018
1	TabletsIBA 01/2018

2	Therapeutics 08/2023 - 10/2021
1	Microspheres (Microsphere) 04/2022
1	Medication Errors (Medication Error) 03/2022
1	Nebulizers and Vaporizers (Inhaler) 12/2021